Lexaria Bioscience (LEXX) Non-cash Items (2022 - 2025)

Lexaria Bioscience has disclosed Non-cash Items across 4 years of filings, most recently posting $26625.0 for Q4 2025.

• Non-cash Items for Q4 2025 came in at $26625.0, down 74.85% year-over-year; the trailing twelve-month figure through Nov 2025 was $26625.0 (down 74.85% YoY), and the FY2025 annual result was $206.0, down 99.98% from the prior year.
• Non-cash Items came in at $26625.0 for Q4 2025 at Lexaria Bioscience, up from $206.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $1.3 million in Q2 2025 to a low of $206.0 in Q3 2025.
• The 4-year median for Non-cash Items is $105869.0 (2024), against an average of $369832.4.
• Across the five-year window, Non-cash Items surged 26898.86% in 2024 and slumped 99.98% in 2025, its largest moves.
• Lexaria Bioscience's Non-cash Items stood at $46375.0 in 2022, then declined by 0.75% to $46025.0 in 2023, then jumped by 130.02% to $105869.0 in 2024, then plunged by 74.85% to $26625.0 in 2025.
• The last three Non-cash Items figures came in at $26625.0 (Q4 2025), $206.0 (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.